Exostoses, Multiple Hereditary
5
0
0
2
Key Insights
Highlights
Success Rate
50% trial completion
Treatment Research
4 treatments under study, led by Blood And Buccal Swab Genetic Test
Research Leaders
7 sponsors active, led by University of British Columbia
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 87/100
40.0%
2 terminated out of 5 trials
50.0%
-36.6% vs benchmark
0%
0 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (5)
Height, Ulnar Length and Forearm Function in Multiple Hereditary Exostoses
An Efficacy and Safety Study of Palovarotene for the Treatment of MO
Gene Mutations and Orthopaedic Symptoms Correlation of Multiple Hereditary Exostoses: Multicentre Project
The Health-Related Quality of Life in Patients With Hereditary Multiple Exostoses
Establishing the Genetic Profile of Multiple Hereditary Exostoses (HME) in Families of BC
Research Network
Common Treatments
- Blood And Buccal Swab Genetic Test1
- Palovarotene1
- Pul1
- Range Of Motion1
Active Sponsors
- University of British Columbia3
- Circle of Care1
- Clementia Pharmaceuticals Inc.1
- MHE Coalition1
- Children's & Women's Health Centre of British Columbia1
Top Investigators
University of British Columbia
Istituto Ortopedico Rizzoli